Leading the Charge for the Morning-After Pill
by Loolwa Khazzoom • February 7, 2010 • Health & Wellness , The Boston Globe
Though the Food and Drug Administration’s official rejection stated that the morning-after pill had not been tested on enough girls under 16, reproductive-rights organizations and activists — including Annie Tummino of Middleborough, MA — assert that the real reason the FDA rejected over-the-counter status was pressure from the Bush administration. This article provides an investigative report on Tummino’s lawsuit against the FDA.
Loolwa Khazzoom has worked with leading media outlets, including The New York Times, CNN, Rolling Stone, and ABC News. In addition, she has published two books and has lectured at prestigious venues including Barnard Center for Research on Women, the Simon Wiesenthal Center, and Harvard University. Loolwa is passionate about health, music, dance, multiculturalism, and Judaism.
